124 related articles for article (PubMed ID: 38840847)
1.
Gutiérrez OM
Kidney Med; 2024 Jun; 6(6):100842. PubMed ID: 38840847
[No Abstract] [Full Text] [Related]
2. Association between
Jiang L; Liu G; Oeser A; Ihegword A; Dickson AL; Daniel LL; Hung AM; Cox NJ; Chung CP; Wei WQ; Stein CM; Feng Q
Elife; 2023 Oct; 12():. PubMed ID: 37882666
[TBL] [Abstract][Full Text] [Related]
3. Effects of Testing and Disclosing Ancestry-Specific Genetic Risk for Kidney Failure on Patients and Health Care Professionals: A Randomized Clinical Trial.
Nadkarni GN; Fei K; Ramos MA; Hauser D; Bagiella E; Ellis SB; Sanderson S; Scott SA; Sabin T; Madden E; Cooper R; Pollak M; Calman N; Bottinger EP; Horowitz CR
JAMA Netw Open; 2022 Mar; 5(3):e221048. PubMed ID: 35244702
[TBL] [Abstract][Full Text] [Related]
4. Dietary Patterns, Apolipoprotein L1 Risk Genotypes, and CKD Outcomes Among Black Adults in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study.
Ilori TO; Brooks MS; Desai PN; Cheung KL; Judd SE; Crews DC; Cushman M; Winkler CA; Shlipak MG; Kopp JB; Naik RP; Estrella MM; Gutiérrez OM; Kramer H
Kidney Med; 2023 May; 5(5):100621. PubMed ID: 37229446
[TBL] [Abstract][Full Text] [Related]
5. Race, APOL1 Risk Variants, and Clinical Outcomes among Older Adults: The ARIC Study.
Chen TK; Coresh J; Daya N; Ballew SH; Tin A; Crews DC; Grams ME
J Am Geriatr Soc; 2021 Jan; 69(1):155-163. PubMed ID: 32894582
[TBL] [Abstract][Full Text] [Related]
6. Association of
Chen TK; Katz R; Estrella MM; Post WS; Kramer H; Rotter JI; Tayo B; Mychaleckyj JC; Wassel CL; Peralta CA
J Am Heart Assoc; 2020 Sep; 9(17):e017039. PubMed ID: 32851884
[TBL] [Abstract][Full Text] [Related]
7. APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study.
Gutiérrez OM; Irvin MR; Zakai NA; Naik RP; Chaudhary NS; Estrella MM; Limou S; Judd SE; Cushman M; Kopp JB; Winkler CA
Am J Kidney Dis; 2020 Jan; 75(1):54-60. PubMed ID: 31563468
[TBL] [Abstract][Full Text] [Related]
8. Association Between
Chen TK; Katz R; Estrella MM; Gutierrez OM; Kramer H; Post WS; Shlipak MG; Wassel CL; Peralta CA
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29269352
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Genetic Characteristics of CKD Patients with High-Risk APOL1 Genotypes.
Elliott MD; Marasa M; Cocchi E; Vena N; Zhang JY; Khan A; Krishna Murthy S; Bheda S; Milo Rasouly H; Povysil G; Kiryluk K; Gharavi AG
J Am Soc Nephrol; 2023 May; 34(5):909-919. PubMed ID: 36758113
[TBL] [Abstract][Full Text] [Related]
10. APOL1 risk variants, race, and progression of chronic kidney disease.
Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein L1 Genotypes and the Association of Urinary Potassium Excretion with CKD Progression.
Ilori TO; Liu J; Rodan AR; Verma A; Mills KT; He J; Winkler CA; Dupuis J; Anderson CAM; Waikar SS
Clin J Am Soc Nephrol; 2022 Oct; 17(10):1477-1486. PubMed ID: 36400568
[TBL] [Abstract][Full Text] [Related]
12. Podocyte density is reduced in kidney allografts with high-risk APOL1 genotypes at transplantation.
Chen DP; Zaky ZS; Schold JD; Herlitz LC; El-Rifai R; Drawz PE; Bruggeman LA; Barisoni L; Hogan SL; Hu Y; O'Toole JF; Poggio ED; Sedor JR
Clin Transplant; 2021 Apr; 35(4):e14234. PubMed ID: 33511679
[TBL] [Abstract][Full Text] [Related]
13. Kidney Disease Progression in Membranous Nephropathy among Black Participants with High-Risk APOL1 Genotype.
Chen DP; Henderson CD; Anguiano J; Aiello CP; Collie MM; Moreno V; Hu Y; Hogan SL; Falk RJ;
Clin J Am Soc Nephrol; 2023 Mar; 18(3):337-343. PubMed ID: 36763808
[TBL] [Abstract][Full Text] [Related]
14.
Chen TK; Tin A; Peralta CA; Appel LJ; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
Clin J Am Soc Nephrol; 2017 Nov; 12(11):1771-1777. PubMed ID: 29051146
[TBL] [Abstract][Full Text] [Related]
15.
Doshi MD; Ortigosa-Goggins M; Garg AX; Li L; Poggio ED; Winkler CA; Kopp JB
J Am Soc Nephrol; 2018 Apr; 29(4):1309-1316. PubMed ID: 29339549
[TBL] [Abstract][Full Text] [Related]
16. Association between
Jiang L; Liu G; Oeser A; Ihegword A; Dickson AL; Daniel LL; Hung AM; Cox NJ; Chung CP; Wei WQ; Stein CM; Feng Q
medRxiv; 2023 Sep; ():. PubMed ID: 36747677
[TBL] [Abstract][Full Text] [Related]
17. Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.
Mena-Gutierrez AM; Reeves-Daniel AM; Jay CL; Freedman BI
Transplantation; 2020 Jan; 104(1):27-32. PubMed ID: 31449181
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Kidney Function Decline Associated with APOL1 Genotypes: Results from AASK.
Tin A; Grams ME; Estrella M; Lipkowitz M; Greene TH; Kao WHL; Li L; Appel LJ
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1353-1359. PubMed ID: 27230965
[TBL] [Abstract][Full Text] [Related]
19. Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
Santoriello D; Husain SA; De Serres SA; Bomback AS; Crew RJ; Vasilescu ER; Serban G; Campenot ES; Kiryluk K; Mohan S; Hawkins GA; Hicks PJ; Cohen DJ; Radhakrishnan J; Stokes MB; Markowitz GS; Freedman BI; D'Agati VD; Batal I
Kidney Int; 2018 Dec; 94(6):1189-1198. PubMed ID: 30287079
[TBL] [Abstract][Full Text] [Related]
20. The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival.
Lee BT; Kumar V; Williams TA; Abdi R; Bernhardy A; Dyer C; Conte S; Genovese G; Ross MD; Friedman DJ; Gaston R; Milford E; Pollak MR; Chandraker A
Am J Transplant; 2012 Jul; 12(7):1924-8. PubMed ID: 22487534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
